Three quick notes:
1. The antitrust issues stem from the foot and ankle offerings, since Wright Medical focuses on the lower extremities and small bones.
2. Larry Biegelsen, a senior analyst at Wells Fargo, thinks Stryker will divest Wright Medical’s STAR ankle business, which has 70 percent share in the total ankle replacement market.
3. Premarket on Nov. 4, Wright Medical stock was up 31 percent while Stryker was down 3 percent.
More articles on orthopedic devices:
Smith+Nephew Q3 revenue up 6.5% to $1.2B: 5 key notes
Alphatec posts Q3 loss—6 insights
Conformis revenue down 40% in Q3, net loss hits $8.7M: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.